US Bancorp’s Cross Country Healthcare CCRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.35K | Sell |
178
-6
| -3% | -$71 | ﹤0.01% | 3842 |
|
|
2026
Q1 | $1.73K | Sell |
184
-370
| -67% | -$3.31K | ﹤0.01% | 3834 |
|
|
2025
Q4 | $4.49K | Sell |
554
-651
| -54% | -$7.11K | ﹤0.01% | 3576 |
|
|
2025
Q3 | $17.1K | Hold |
1,205
| – | – | ﹤0.01% | 3123 |
|
|
2025
Q2 | $15.7K | Hold |
1,205
| – | – | ﹤0.01% | 3265 |
|
|
2025
Q1 | $17.9K | Sell |
1,205
-306
| -20% | -$5.26K | ﹤0.01% | 3218 |
|
|
2024
Q4 | $27.4K | Sell |
1,511
-3,223
| -68% | -$43.4K | ﹤0.01% | 3020 |
|
|
2024
Q3 | $63.6K | Buy |
4,734
+4,691
| +10,909% | +$69.2K | ﹤0.01% | 2618 |
|
|
2024
Q2 | $595 | Sell |
43
-271
| -86% | -$4.29K | ﹤0.01% | 3847 |
|
|
2024
Q1 | $5.88K | Sell |
314
-828
| -73% | -$16.6K | ﹤0.01% | 3489 |
|
|
2023
Q4 | $25.9K | Sell |
1,142
-25
| -2% | -$542 | ﹤0.01% | 2941 |
|
|
2023
Q3 | $28.9K | Sell |
1,167
-52
| -4% | -$1.31K | ﹤0.01% | 2704 |
|
|
2023
Q2 | $34.2K | Sell |
1,219
-57
| -4% | -$1.42K | ﹤0.01% | 2710 |
|
|
2023
Q1 | $28.5K | Sell |
1,276
-473
| -27% | -$12.4K | ﹤0.01% | 2804 |
|
|
2022
Q4 | $46.5K | Sell |
1,749
-97
| -5% | -$3.17K | ﹤0.01% | 2573 |
|
|
2022
Q3 | $53K | Buy |
1,846
+378
| +26% | +$9.72K | ﹤0.01% | 2500 |
|
|
2022
Q2 | $30K | Buy |
1,468
+220
| +18% | +$4.12K | ﹤0.01% | 2838 |
|
|
2022
Q1 | $27K | Buy |
+1,248
| New | +$27.1K | ﹤0.01% | 2914 |
|
|
2018
Q4 | – | Sell |
-146
| Closed | -$1K | – | 3589 |
|
|
2018
Q3 | $1K | Buy |
146
+94
| +181% | +$960 | ﹤0.01% | 3547 |
|
|
2018
Q2 | $1K | Hold |
52
| – | – | ﹤0.01% | 3539 |
|
|
2018
Q1 | $1K | Hold |
52
| – | – | ﹤0.01% | 3532 |
|
|
2017
Q4 | $1K | Hold |
52
| – | – | ﹤0.01% | 3519 |
|
|
2017
Q3 | $1K | Sell |
52
-129
| -71% | -$1.62K | ﹤0.01% | 3475 |
|
|
2017
Q2 | $2K | Hold |
181
| – | – | ﹤0.01% | 3382 |
|
|
2017
Q1 | $3K | Hold |
181
| – | – | ﹤0.01% | 3311 |
|
|
2016
Q4 | $3K | Hold |
181
| – | – | ﹤0.01% | 3293 |
|
|
2016
Q3 | $2K | Sell |
181
-7,310
| -98% | -$96.3K | ﹤0.01% | 3342 |
|
|
2016
Q2 | $105K | Buy |
7,491
+181
| +2% | +$2.4K | ﹤0.01% | 2019 |
|
|
2016
Q1 | $85K | Sell |
7,310
-213
| -3% | -$2.71K | ﹤0.01% | 2106 |
|
|
2015
Q4 | $123K | Sell |
7,523
-1,800
| -19% | -$28.6K | ﹤0.01% | 1948 |
|
|
2015
Q3 | $126K | Buy |
9,323
+4,753
| +104% | +$64.6K | ﹤0.01% | 1946 |
|
|
2015
Q2 | $58K | Buy |
4,570
+300
| +7% | +$3.4K | ﹤0.01% | 2459 |
|
|
2015
Q1 | $51K | Buy |
+4,270
| New | +$48.9K | ﹤0.01% | 2527 |
|
|
2014
Q4 | – | Sell |
-55
| Closed | -$1K | – | 3533 |
|
|
2014
Q3 | $1K | Buy |
+55
| New | +$422 | ﹤0.01% | 3427 |
|
Other funds holding CCRN
GCL
SCM
OBAM
DIA
US Bancorp's CCRN Position: Q2 2026 in Review
US Bancorp reduced its Cross Country Healthcare (CCRN) stake by 3.3% in Q2 2026, selling an estimated $71 and leaving 178 shares worth $2.35K. The position accounts for ﹤0.01% of the portfolio, ranked #3842.
US Bancorp first reported a position in CCRN in Q3 2014 and has held it in 34 quarters since. The position peaked at $126K in Q3 2015. 151 funds tracked by Wall St. Rank hold CCRN as of Q2 2026.
- US Bancorp held 178 shares of Cross Country Healthcare worth $2.35K as of Q2 2026.
- US Bancorp sold 6 Cross Country Healthcare shares in Q2 2026, an estimated $71.
- Cross Country Healthcare made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #3842 holding.
- US Bancorp first reported a position in Cross Country Healthcare in Q3 2014 and has held it in 34 quarters since.
- US Bancorp's Cross Country Healthcare position peaked at $126K in Q3 2015.
- 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.